Prevalence of Comorbidities, Overweight and Obesity in an International Sample of People with Multiple Sclerosis and Associations with Modifiable Lifestyle Factors
Open Access
- 5 February 2016
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 11 (2) , e0148573
Abstract
Multiple sclerosis (MS) is a chronic neurological disorder, often affecting young people. Comorbid disorders such as depression, anxiety and hypertension are common and can affect disease course, treatment, and quality of life (QOL) of people with MS (PwMS). The associations between comorbidities, body mass index (BMI) and health outcomes are not well studied in MS, although research shows most PwMS are overweight. Most data on the prevalence of comorbidities and obesity in PwMS comes from North American populations. This study describes the prevalence of comorbidities, overweight and obesity and associations with modifiable factors in an international sample of PwMS recruited online through social media, MS societies and websites. The online survey consisted of validated and researcher-devised instruments to assess self-reported health outcomes and lifestyle behaviors. Of the 2399 respondents, 22.5% were overweight, 19.4% were obese and 67.2% reported at least one comorbidity, with back pain (36.2%), depression (31.7%), anxiety (29.1%) and arthritis (13.7%) most prevalent and most limiting in daily activities. Obesity and most comorbid disorders were significantly more prevalent in North America. Obese participants were more likely to have comorbidities, especially diabetes (OR 4.8) and high blood pressure (OR 4.5) but also depression (OR 2.2). Being overweight, obese, or a former, or current smoker was associated with an increase in the number of comorbidities; while healthy diet, physical activity (borderline significant) and moderate alcohol consumption were associated with decreased number of comorbidities. Increasing number of comorbidities was related to worse QOL, increased odds of disability and prior relapse. Obese PwMS had higher odds of disability and lower QOL. The associations between BMI, comorbidities and health outcomes are likely to be bi-directional and associated with lifestyle behaviors. Preventing and treating comorbid disorders and obesity in PwMS is warranted, and advice regarding healthy and risky lifestyle may assist in improving health outcomes.Keywords
This publication has 46 references indexed in Scilit:
- Association of fish consumption and omega 3 supplementation with quality of life, disability and disease activity in an international cohort of people with multiple sclerosisInternational Journal of Neuroscience, 2013
- Methodology of an International Study of People with Multiple Sclerosis Recruited through Web 2.0 Platforms: Demographics, Lifestyle, and Disease CharacteristicsNeurology Research International, 2013
- Weight status and disability in multiple sclerosis: An examination of bi-directional associations over a 24-month periodMultiple Sclerosis and Related Disorders, 2012
- Weight Status in Persons with Multiple Sclerosis: Implications for Mobility OutcomesJournal of Obesity, 2012
- Cumulative impact of comorbidity on quality of life in MSActa Neurologica Scandinavica, 2011
- Physical Activity and Self-Reported Cardiovascular Comorbidities in Persons with Multiple Sclerosis: Evidence from a Cross-Sectional AnalysisNeuroepidemiology, 2011
- Smokers with Multiple Sclerosis Are More Likely to Report Comorbid Autoimmune DiseasesNeuroepidemiology, 2011
- Vascular comorbidity is associated with more rapid disability progression in multiple sclerosisNeurology, 2010
- The self‐administered comorbidity questionnaire: A new method to assess comorbidity for clinical and health services researchArthritis Care & Research, 2003
- Disease Steps in multiple sclerosisNeurology, 1995